NEUROTHERA

neurothera-logo

Medical Device company developing light/laser based technologies for the treatment of Brain diseases and disorders.

#SimilarOrganizations #People #Website #More

NEUROTHERA

Industry:
Health Care Medical Device

Website Url:
http://www.neurothera.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Font Awesome Contact Form 7 Wordpress 4.9


Similar Organizations

braincom-logo

Braincom

Braincom will provide implantable and wearable electronics for treatment of brain disorders.

cardiac-dimensions-logo

Cardiac Dimensions

Cardiac Dimensions is a medical device company developing tools and techniques for the treatment of heart failure and related conditions.

palyon-medical-logo

Palyon Medical

Palyon Medical Corporation, a medical device company, develops technologies for the treatment of neurological diseases.

Current Employees Featured

brian-pryor_image

Brian Pryor
Brian Pryor CEO /co-founder @ Neurothera
CEO /co-founder
2016-01-01

Founder


brian-pryor_image

Brian Pryor

Official Site Inspections

http://www.neurothera.com

  • Host name: server.pthera.com
  • IP address: 208.87.225.189
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Neurothera"

NeuroThera

We are NeuroThera | Drug-Free | Surgery-Free | We are the leader of photobiomodulation technology and devices for neurotherapy and brain health. We are developing advanced technologies for transcranial light therapy for …See details»

NeuroThera Effectiveness and Safety Trial 3 | Stroke - AHA/ASA …

Oct 7, 2014 · In this issue of Stroke, Hacke et al 1 for the NeuroThera Effectiveness and Safety Trial 3 (NEST 3) Committees and Investigators report the results of a phase III, randomized, …See details»

Infrared Laser Therapy for Ischemic Stroke: A New …

Apr 26, 2007 · Background and Purpose— The NeuroThera Effectiveness and Safety Trial-1 (NEST-1) study evaluated the safety and preliminary effectiveness of the NeuroThera Laser System in the ability to improve 90-day outcomes in …See details»

NeuroThera® Efficacy and Safety Trial – 3 (NEST-3): A Double …

Sep 27, 2012 · NeuroThera® Efficacy and Safety Trial-3 is a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study that will enroll 1000 subjects at up to 50 …See details»

Transcranial Laser Therapy in Acute Stroke Treatment:

Oct 7, 2014 · We studied transcranial laser therapy in a double-blind, sham-controlled randomized clinical trial intended to enroll 1000 patients with acute ischemic stroke treated ≤24 hours after …See details»

Infrared Laser Therapy for Ischemic Stroke A New Treatment …

The NeuroThera Laser System therapeutic approach involves use of infrared laser technology and has shown significant and sustained beneficial effects in animal models of ischemic stroke .See details»

NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind ...

Sep 27, 2012 · NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of …See details»

Initial studies show new laser treatment to be safe and effective in ...

The NeuroThera ® Laser System (PhotoThera, Carlsbad, CA) uses infrared laser technology to achieve photobiostimulation; the technique is believed to stimulate the production of ATP, …See details»

NeuroThera® Efficacy and Safety Trial - Wiley Online Library

Sep 27, 2012 · NeuroThera ® Efficacy and Safety Trial‐3 is a double‐blind, randomized, sham‐controlled, parallel group, multicenter, pivotal study that will enroll 1000 subjects at up to …See details»

NeuroThera®Efficacy and Safety Trial - 3 (NEST-3): a double-blind ...

Sep 27, 2012 · The NeuroThera® Efficacy and Safety Trial-1 was strongly positive for 90-day functional benefit with transcranial laser therapy, and post hoc analyses of the subsequent …See details»

Infrared laser therapy for ischemic stroke: a new treatment …

Apr 26, 2007 · The NeuroThera Laser System therapeutic approach involves use of infrared laser technology and has shown significant and sustained beneficial effects in animal models of …See details»

transcranial Photobiomodulation – Soterix Medical

As opposed to using LED sources that have “un-controlled” irradiance profiles, the NeuroThera solution uses fiber-coupled laser sources delivering light through a beam homogenizer. This …See details»

Neurotherapy: Definition, Uses, Types, Warnings - Verywell Health

Jul 20, 2024 · Neurotherapy uses neurotechnology for therapeutic application. It uses a person's brainwave activity to help them understand how they can self-regulate their state of mind to …See details»

Alzheimer's Disease | NeuroTherapia, Inc. | United States

NeuroTherapia is developing oral, small molecule therapeutics that inhibit microglia cells, which are known to express proteins that drive inflammation in the CNS. We believe our therapies …See details»

Transcranial Laser Therapy in Acute Stroke Treatment:

Oct 7, 2014 · We studied transcranial laser therapy in a double-blind, sham-controlled randomized clinical trial intended to enroll 1000 patients with acute ischemic stroke treated ≤24 hours after …See details»

NeuroThera Effectiveness and Safety Trial 3 - AHA/ASA Journals

In this issue of Stroke, Hacke et al1 for the NeuroThera Effectiveness and Safety Trial 3 (NEST 3) Committees and Investigators report the results of a phase III, randomized, dou-ble-blind …See details»

School of Neurotherapy - YouTube

The School of Neurotherapy is an online collection of resources for students of all ages hungry for data on how to interpret and use EEG data to improve lives.See details»

Effectiveness and Safety of Transcranial Laser Therapy for Acute ...

Jan 12, 2009 · Background and Purpose—We hypothesized that transcranial laser therapy (TLT) can use near-infrared laser technology to treat acute ischemic stroke. The NeuroThera …See details»

linkstock.net © 2022. All rights reserved